News and Announcements
The Agency Group (ASX: AU1) further expands in WA property market with acquisition
- Published April 10, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- The Agency Group Australia to acquire all of the issued shares of Vicus Residential (the residential sales and management division of The Vicus Group)
- The Agency has entered into a binding term sheet to acquire all of the issued shares of Vicus Residential for 41.25 million ordinary shares in The Agency and a $50,000 cash payment
- Vicus Residential acquisition will add over 200 rental properties, increasing The Agency’s property managements to over 700 post acquisition
About Ausnet Financial Services (ASX: AU1)
Ausnet are disrupting the real-estate industry by being the first fully integrated real estate and financial services company. The Company uses property transactions and/or financing events to review and service a client’s complete finance and wealth requirements.
Ausnet wish to raise up to $2.0 million of additional equity capital via the issue of 100m shares at an issue price of $0.02 per share pursuant to a placement (“Placement”). The Company has the ability to accept oversubscriptions of an additional $1.0m.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
